test and retatrutide What is Research Peptide Retatrutide Half Life: A Doctor
Description
All participants received treatment for at least 52 weeks, with a maximum treatment duration of 104 weeks or until the study was completed to collect and evaluate major adverse cardiovascular events (MACE)

For semaglutide weight loss purposes, the 2.4 mg maintenance dose is where the major clinical trial results were measured, showing approximately 15% body weight reduction over 68 weeks in the STEP 1 trial
Lastly, the 8 mg/3 mL pen delivers the highest amount of medication per pen and the maximum weekly dose of 2 mg

Zakaria H, Alshehhi S, Caccelli M, Ozkan C, Kattan J, Jafaar Z, et al